Osaic Holdings
KTTAW icon

Osaic Holdings’s Pasithea Therapeutics Warrants KTTAW Stock Holding History

Osaic Holdings’s Portfolio KTTAW Stock Details KTTAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$150 Buy
+15,000
New +$183 ﹤0.01% 7592

Other funds holding KTTAW

KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

Osaic Holdings's KTTAW Position: Q1 2026 in Review

Osaic Holdings opened a new position in Pasithea Therapeutics Warrants (KTTAW) in Q1 2026: 15,000 shares worth $150. The stake represents ﹤0.01% of the portfolio and ranks #7592 among its holdings.

5 funds tracked by Wall St. Rank hold KTTAW as of Q1 2026.

  • Osaic Holdings held 15,000 shares of Pasithea Therapeutics Warrants worth $150 as of Q1 2026.
  • Pasithea Therapeutics Warrants was a new Osaic Holdings position in Q1 2026.
  • Pasithea Therapeutics Warrants made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7592 holding.
  • 5 funds tracked by Wall St. Rank held Pasithea Therapeutics Warrants as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.